You are here

Front > Search FHI 360

Search FHI 360

Start a New Search

Search within these results

Published researchResearch utilizationHealth and access to care

4 Results Found

  • Published research

    Incidence of herpes simplex virus type 2 infection among African women using depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: A nested randomized trial

  • Published research

    Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial

    The authors found that women who self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) led to a more than 50 percent increase in pregnancy protection through 12 months compared with provider-administered injection. The findings demonstrate that self-injection can address the stubborn problem of early contraceptive discontinuation and that community health workers can safely train women to self-inject. Malawi plans to introduce DMPA-SC self-injection based on these positive findings.
  • Published research

    Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam

    This research finds conclusive evidence that methadone maintenance treatment (MMT) is more costeffective than center-based compulsory treatment (CCT) in reducing heroin use, blood-borne virus risk behaviors, drug-related illegal behaviors and monthly drug spending. The authors recommend that policymakers consider allocation of resources for MMT treatment a higher priority and scale down CCT models.
  • Published research

    Attitudes and perceptions toward novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey

    The authors conducted a survey of stakeholders with experience and expertise in microbicide and HIV prevention clinical trials. They found that methods that require no additional input from the participant and no modifications to the existing ring product are viewed as more acceptable to trial participants and more feasible to implement in the field.